D
Tarsus Pharmaceuticals, Inc. TARS
$58.85 $2.243.96% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 102.66M 78.34M 66.41M 48.12M 40.81M
Total Other Revenue -- -- -- -- --
Total Revenue 102.66M 78.34M 66.41M 48.12M 40.81M
Cost of Revenue 21.83M 19.62M 21.80M 15.37M 15.32M
Gross Profit 80.83M 58.72M 44.61M 32.75M 25.49M
SG&A Expenses 103.01M 85.00M 69.03M 57.91M 58.79M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 124.84M 104.62M 90.83M 73.28M 74.12M
Operating Income -22.18M -26.28M -24.42M -25.16M -33.30M
Income Before Tax -20.34M -25.12M -23.11M -23.42M -33.29M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -20.34M -25.12M -23.11M -23.42M -33.29M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -20.34M -25.12M -23.11M -23.42M -33.29M
EBIT -22.18M -26.28M -24.42M -25.16M -33.30M
EBITDA -21.73M -25.82M -23.99M -24.88M -33.06M
EPS Basic -0.48 -0.64 -0.60 -0.61 -0.88
Normalized Basic EPS -0.30 -0.42 -0.33 -0.38 -0.52
EPS Diluted -0.48 -0.64 -0.60 -0.61 -0.88
Normalized Diluted EPS -0.30 -0.42 -0.33 -0.38 -0.52
Average Basic Shares Outstanding 42.36M 39.35M 38.56M 38.38M 37.82M
Average Diluted Shares Outstanding 42.36M 39.35M 38.56M 38.38M 37.82M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --